Dr Reddy’s launches Daptomycin in US

Dr Reddy’s Daptomycin for injection is available in single-dose 15 ml vials containing 500 mg of Daptomycin

By Author  |  Business Bureau  |  Published: 15th May 2019  8:50 pm

Hyderabad: Hyderabad-based pharmaceuticals company Dr Reddy’s Laboratories launched Daptomycin for injection, 500 mg/vial single-dose vial, a therapeutic equivalent generic version of Cubicin for injection, approved by the US Food and Drug Administration.

The Cubicin for injection brand and generic had US sales of approximately $640.8 million for the last one year ending March 2019, according to IQVIA Health. Cubicin is a trademark of Merck Sharp & Dohme Corp.

Dr Reddy’s Daptomycin for injection is available in single-dose 15 ml vials containing 500 mg of Daptomycin.

Now you can get handpicked stories from Telangana Today on WhatsApp / Telegram everyday. Click this link to subscribe and save this number 9182563636 on your contacts.